Efficient and Cost-Effective Monoclonal Antibody Scale-Up

news 15. febrero 2023 07:00

The leading article of BioNews No. 58 reveals what is key when it comes to the development of a robust, efficient, and cost-effective research and development process for mAbs. Additionally, we offer you helpful suggestions and ideas for your daily lab life, including information on workflows, products, and initiatives, as well as on the subject of sustainability at Eppendorf.

Never miss a BioNews – subscribe for free to the online edition

Since 1993, Eppendorf BioNews has been widely regarded as a highly popular source of information for researchers and scientific personnel. It is published twice a year and can be subscribed to for free at www.eppendorf.com/bionews

Leer menos